Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. MRK

Go back to Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
(NASDAQ: SPTX) Delayed: 19.31 +0.34 (1.79%)
Previous Close $18.97    52 Week High $ 
Open $19.62    52 Week Low $ 
Day High $20.04    P/E N/A 
Day Low $18.73    EPS $ 
Volume 202,734